Presentations and Events 

Chemomab Corporate Overview | March 9-10, Global Life Sciences Conference

View/Download PDF 

Filed by Anchiano Therapeutics Ltd. Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended
Subject Company: Chemomab Ltd.

Chemomab Corporate Overview | January 2021

View/Download PDF 

Filed by Anchiano Therapeutics Ltd. Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended
Subject Company: Chemomab Ltd.

Corporate Presentation | July 2020

View/Download PDF 

Ladenburg Thalmann 2019 Healthcare Conference | September 24, 2019

Click here for webcast 

View/Download PDF

Corporate Update Call | September 24, 2019

Link

Baird’s 2019 Global Healthcare Conference | September 5, 2019

Click here for webcast 

View/Download PDF

MIXiii-BIOMED 2019 | May 16, 2019 

View/Download PDF

Oppenheimer 29th Annual Healthcare Conference | March 20, 2019 

View/Download PDF